Cutaquig and Lorcaserin Extended-Release Tablets
Determining the interaction of Cutaquig and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: immune globulin subcutaneous
Brand name: Cutaquig, Cuvitru, Hizentra, Vivaglobin, Xembify
Synonyms: Cutaquig (subcutaneous)
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cutaquig-Lorcaserin Hydrochloride
- Cutaquig-Lorcaserin Tablets
- Cutaquig-Lorcet
- Cutaquig-Lorcet Plus
- Cutaquig-Lorcet Tablets
- Cutaquig-Lorlatinib
- Lorcaserin Extended-Release Tablets-Cutar Emulsion Topical
- Lorcaserin Extended-Release Tablets-Cutivate
- Lorcaserin Extended-Release Tablets-Cutivate (Fluticasone Cream and Lotion)
- Lorcaserin Extended-Release Tablets-Cutivate (Fluticasone Ointment)
- Lorcaserin Extended-Release Tablets-Cutivate Cream
- Lorcaserin Extended-Release Tablets-Cutivate Lotion